Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|August 28, 2007
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assaysC M Britten, C Gouttefangeas, M J P Welters, et al.
Standards in Genomic Sciences|February 10, 2011
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshopCarsten Kettner, Dawn Field, Susanna-Assunta Sansone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2021
Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-βJonathan D Silk, Rachel J M Abbott, Katherine J Adams, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumorsMartin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy BiomarkersLisa H Butterfield, A Karolina Palucka, Cedrik M Britten, et al.
Nature Medicine|April 9, 2025
Autologous T cell therapy for PRAME<sup>+</sup> advanced solid tumors in HLA-A*02<sup>+</sup> patients: a phase 1 trialMartin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Cancer Immunology Research|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic CancerApostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, et al.
Nature|December 21, 2018
Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Journal of Translational Medicine|October 5, 2012
Cancer classification using the Immunoscore: a worldwide task forceJérôme Galon, Franck Pagès, Francesco M Marincola, et al.
Nature|February 9, 2019
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Pageof 11